Semaglutide
Semaglutide is a prescription medication originally developed to treat type 2 diabetes by improving blood sugar control. It belongs to a class of drugs called GLP-1 receptor agonists, which mimic a natural hormone that regulates blood sugar and appetite. Recently, it has gained popularity for weight management, as it helps reduce hunger and increase feelings of fullness, leading to lower calorie intake and significant weight loss.

Semaglutide is administered as a once-weekly injection or a daily oral tablet. It slows gastric emptying and reduces glucose production in the liver, making it effective for both diabetes management and obesity treatment. Common side effects include nausea, vomiting, diarrhea, and constipation, though these often subside over time. Rare but serious side effects may include pancreatitis and gallbladder issues. It is typically used alongside diet and exercise and requires careful monitoring by a healthcare provider to ensure safety and effectiveness.